June 5, 2018Ionis Closes Strategic Collaboration with Biogen to Develop Drugs for a Broad Range of Neurological Diseases
Ionis Pharmaceuticals Publishes Paper on Growth of RNA-targeted Therapeutics in Cell Metabolism
IONIS NEURO-TTR Phase 3 Clinical Trial Highlighted at American College of Cardiology (ACC) Annual Meeting
FDA Accepts Plazomicin’s NDA with Priority Review for the Treatment of Complicated Urinary Tract Infections and Bloodstream Infections
Ionis’ SPINRAZA Recognized with Prestigious Prix Galien Award for Best Biotechnology Product
We have numerous ongoing clinical trials designed to evaluate our drugs in a variety of health conditions. More »
No upcoming events at this time...